Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 78

1.

A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer.

Ho-Pun-Cheung A, Assenat E, Bascoul-Mollevi C, Bibeau F, Boissière-Michot F, Thezenas S, Cellier D, Azria D, Rouanet P, Senesse P, Ychou M, Lopez-Crapez E.

Pharmacogenomics J. 2011 Dec;11(6):437-43. doi: 10.1038/tpj.2010.62. Epub 2010 Jul 20.

PMID:
20644561
[PubMed - indexed for MEDLINE]
2.

Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.

Bonnen M, Crane C, Vauthey JN, Skibber J, Delclos ME, Rodriguez-Bigas M, Hoff PM, Lin E, Eng C, Wong A, Janjan NA, Feig BW.

Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1098-105.

PMID:
15519780
[PubMed - indexed for MEDLINE]
3.

Biomarkers for cetuximab-based neoadjuvant radiochemotherapy in locally advanced rectal cancer.

Grimminger PP, Danenberg P, Dellas K, Arnold D, Rödel C, Machiels JP, Haustermans K, Debucquoy A, Velenik V, Sempoux C, Bracko M, Hölscher AH, Semrau R, Yang D, Danenberg K, Lenz HJ, Vallböhmer D.

Clin Cancer Res. 2011 May 15;17(10):3469-77. doi: 10.1158/1078-0432.CCR-10-2273. Epub 2011 May 10.

PMID:
21558395
[PubMed - indexed for MEDLINE]
Free Article
4.

XRCC1 gene polymorphism for prediction of response and prognosis in the multimodality therapy of patients with locally advanced rectal cancer.

Grimminger PP, Brabender J, Warnecke-Eberz U, Narumiya K, Wandhöfer C, Drebber U, Bollschweiler E, Hölscher AH, Metzger R, Vallböhmer D.

J Surg Res. 2010 Nov;164(1):e61-6. doi: 10.1016/j.jss.2010.08.002. Epub 2010 Sep 16.

PMID:
20863523
[PubMed - indexed for MEDLINE]
5.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
[PubMed - indexed for MEDLINE]
6.

Does rectal wall tumor eradication with preoperative chemoradiation permit a change in the operative strategy?

Zmora O, Dasilva GM, Gurland B, Pfeffer R, Koller M, Nogueras JJ, Wexner SD.

Dis Colon Rectum. 2004 Oct;47(10):1607-12.

PMID:
15540288
[PubMed - indexed for MEDLINE]
7.

Thymidylate synthase genotypes and tumour regression in stage II/III rectal cancer patients after neoadjuvant fluorouracil-based chemoradiation.

Stoehlmacher J, Goekkurt E, Mogck U, Aust DE, Kramer M, Baretton GB, Liersch T, Ehninger G, Jakob C.

Cancer Lett. 2008 Dec 18;272(2):221-5. doi: 10.1016/j.canlet.2008.07.008. Epub 2008 Aug 21.

PMID:
18722050
[PubMed - indexed for MEDLINE]
8.

T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival.

Theodoropoulos G, Wise WE, Padmanabhan A, Kerner BA, Taylor CW, Aguilar PS, Khanduja KS.

Dis Colon Rectum. 2002 Jul;45(7):895-903.

PMID:
12130878
[PubMed - indexed for MEDLINE]
9.

A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation.

Terrazzino S, Agostini M, Pucciarelli S, Pasetto LM, Friso ML, Ambrosi A, Lisi V, Leon A, Lise M, Nitti D.

Pharmacogenet Genomics. 2006 Nov;16(11):817-24.

PMID:
17047490
[PubMed - indexed for MEDLINE]
10.

Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.

Liersch T, Langer C, Ghadimi BM, Kulle B, Aust DE, Baretton GB, Schwabe W, Häusler P, Becker H, Jakob C.

J Clin Oncol. 2006 Sep 1;24(25):4062-8.

PMID:
16943523
[PubMed - indexed for MEDLINE]
Free Article
11.

Germline polymorphisms may act as predictors of response to preoperative chemoradiation in locally advanced T3 rectal tumors.

Spindler KL, Nielsen JN, Lindebjerg J, Jakobsen A.

Dis Colon Rectum. 2007 Sep;50(9):1363-9.

PMID:
17661145
[PubMed - indexed for MEDLINE]
12.

p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.

Saw RP, Morgan M, Koorey D, Painter D, Findlay M, Stevens G, Clarke S, Chapuis P, Solomon MJ.

Dis Colon Rectum. 2003 Feb;46(2):192-202.

PMID:
12576893
[PubMed - indexed for MEDLINE]
13.

Can rectal cancers with pathologic T0 after neoadjuvant chemoradiation (ypT0) be treated by transanal excision alone?

Tulchinsky H, Rabau M, Shacham-Shemueli E, Goldman G, Geva R, Inbar M, Klausner JM, Figer A.

Ann Surg Oncol. 2006 Mar;13(3):347-52. Epub 2006 Feb 1.

PMID:
16450221
[PubMed - indexed for MEDLINE]
14.

Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome.

Moore HG, Shia J, Klimstra DS, Ruo L, Mazumdar M, Schwartz GK, Minsky BD, Saltz L, Guillem JG.

Ann Surg Oncol. 2004 Nov;11(11):955-61. Epub 2004 Oct 15.

PMID:
15525823
[PubMed - indexed for MEDLINE]
15.

Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.

Pucciarelli S, Toppan P, Friso ML, Russo V, Pasetto L, Urso E, Marino F, Ambrosi A, Lise M.

Dis Colon Rectum. 2004 Nov;47(11):1798-807.

PMID:
15622571
[PubMed - indexed for MEDLINE]
16.

Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer.

Park YA, Sohn SK, Seong J, Baik SH, Lee KY, Kim NK, Cho CW.

J Surg Oncol. 2006 Feb 1;93(2):145-50.

PMID:
16425302
[PubMed - indexed for MEDLINE]
17.

Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?

Kuo LJ, Liu MC, Jian JJ, Horng CF, Cheng TI, Chen CM, Fang WT, Chung YL.

Ann Surg Oncol. 2007 Oct;14(10):2766-72. Epub 2007 Jun 6.

PMID:
17551794
[PubMed - indexed for MEDLINE]
18.

Prediction of response to chemoradiation in rectal cancer by a gene polymorphism in the epidermal growth factor receptor promoter region.

Spindler KL, Nielsen JN, Lindebjerg J, Brandslund I, Jakobsen A.

Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):500-4. Epub 2006 Jun 6.

PMID:
16757132
[PubMed - indexed for MEDLINE]
19.

Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer.

Frasson M, Garcia-Granero E, Roda D, Flor-Lorente B, Roselló S, Esclapez P, Faus C, Navarro S, Campos S, Cervantes A.

Cancer. 2011 Jul 15;117(14):3118-25. doi: 10.1002/cncr.25866. Epub 2011 Jan 24.

PMID:
21264832
[PubMed - indexed for MEDLINE]
Free Article
20.

[Predictive factors of tumour response after neoadjuvant chemoradiation for locally advanced rectal cancer and correlation of these factors with survival].

Farnault B, Moureau-Zabotto L, de Chaisemartin C, Esterni B, Lelong B, Viret F, Giovannini M, Monges G, Delpero JR, Bories E, Turrini O, Viens P, Resbeut M.

Cancer Radiother. 2011 Jul;15(4):279-86. doi: 10.1016/j.canrad.2011.01.005. Epub 2011 Apr 22. French.

PMID:
21515083
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk